// App-Quantinova.ai

: Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact

Researchers

Presenter

  • Martina Bonifazi

Principal Investigators

  • Eva Negri

  • Joseph Jacob

  • Ryoko Egashira

  • Sara Piciucchi

  • Federico Mei

  • Angelo De Lauretis

  • Dina Visca

  • Nicole Goh

  • Matteo Bonini

  • Carlo La Vecchia

  • Felix Chua

  • Vasileios Kouranos

  • George Margaritopoulos

  • Maria Kokosi

  • Toby M Maher

  • Stefano Gasparini

  • Armando Gabrielli

  • Athol U Wells

  • Elisabetta Renzoni

Medical Centers

  • Department of Biomedical Sciences and Public Health, Universitá Politecnica delle Marche, and Pulmonary Diseases Unit, Department of Internal Medicine, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Ancona, Italy

  • Radiology, Department of Medicine and Surgery,Università di Parma, Parma (PR , Italy

  • Department of Biomedical and Clinical Sciences Luigi Sacco,Università degli Studi di Milano, Milano (MI, Italy

  • Department of Respiratory Medicine and Centre for Medical Image Computing, University College London, London, United Kingdom,

  • Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  • Radiology Department, Ospedale GB Morgagni, Forlì, Italy

  • Pulmonary Diseases Unit, Department of Internal Medicine, Azienda Ospedali Riuniti, Ancona, Italy

  • Pulmonary Diseases Unit, Azienda Ospedaliera Guido Salvini, Garbagnate Milanse (MI, Italy

  • Division of Pulmonary Rheabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy

  • Department of Respiratory & Sleep Medicine, Austin Health; Institute for Breathing and Sleep (IBAS), Melbourne, Australia

  • Department of Cardiovascular and Thoracic Sciences,Fondazione Policlinico Universitario A.Gemelli- IRCCS,Università Cattolica del Sacro Cuore, Rome (RM, Italy

  • Clinical Sciences and Community Health, University of Milan, Milan, Italy

  • Interstitial Lung Disease Unit, Royal Brompton Hospital/Imperial College, London, United Kingdom,

  • Interstitial Lung Disease Unit, Manchester University Hospital NHS FT, Wythenshawe Hospital, manchester, United Kingdom

  • Department of Biomedical Sciences and Public Health, Universitá Politecnica delle Marche, and Pulmonary Diseases Unit, Department of Internal Medicine, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Ancona, Italy

  • Department of Clinical and Molecular Sciences, Universita Politecnica delle Marche, Ancona, Italy

Locations

  • Italy

  • United Kingdom

  • Japan

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Interstitial lung disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved